<code id='FB557CCDA8'></code><style id='FB557CCDA8'></style>
    • <acronym id='FB557CCDA8'></acronym>
      <center id='FB557CCDA8'><center id='FB557CCDA8'><tfoot id='FB557CCDA8'></tfoot></center><abbr id='FB557CCDA8'><dir id='FB557CCDA8'><tfoot id='FB557CCDA8'></tfoot><noframes id='FB557CCDA8'>

    • <optgroup id='FB557CCDA8'><strike id='FB557CCDA8'><sup id='FB557CCDA8'></sup></strike><code id='FB557CCDA8'></code></optgroup>
        1. <b id='FB557CCDA8'><label id='FB557CCDA8'><select id='FB557CCDA8'><dt id='FB557CCDA8'><span id='FB557CCDA8'></span></dt></select></label></b><u id='FB557CCDA8'></u>
          <i id='FB557CCDA8'><strike id='FB557CCDA8'><tt id='FB557CCDA8'><pre id='FB557CCDA8'></pre></tt></strike></i>

          hotspot

          hotspot

          author:focus    Page View:816
          JUUL store sign -- health coverage from STAT
          Stephanie Keith/Getty Images

          Documents released this week shed new light on an aggressive strategy from vape maker Juul to court Black leaders, including the Rev. Al Sharpton, to publicly support its e-cigarettes.

          Beginning in 2018, Juul executives, including the company’s CEO, discussed six- and seven-figure partnerships with civil rights organizations, one of which would have seen it send as much as $7 million to Sharpton’s group, according to internal emails and documents that were released this week as part of a legal settlement with the state of North Carolina.

          advertisement

          It’s not clear how much the company ultimately spent on the partnerships.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more
          KalVista pill reduced swelling 'attacks' caused by genetic disease
          KalVista pill reduced swelling 'attacks' caused by genetic disease

          AdobeKalVistaPharmaceuticalssaidTuesdaythatitsoral,on-demandtreatmentfortheswelling“attacks”commonly

          read more
          How to save PrEP access — and even expand it
          How to save PrEP access — and even expand it

          UndertheAffordableCareAct,healthinsurersarerequiredtocoverallcostsassociatedwithpreventivecare—inclu

          read more

          Diverse clinical trials: Why aren’t we there yet?

          KeishaOkaforforSTATClinicaltrialsarecriticaltoadvancinglifesavingmedicationsandtreatments.ButtheU.S.